Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00273_DB00880_nanopub.RAYJ88bZQr35W-WIjTUsrHSLC_BSNohb30hGsDex8YfAg#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00273_DB00880 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00273_DB00880 label "DDI between Topiramate and Chlorothiazide - Thiazide diuretics such as chlorothiazide may enhance the hypokalemic effect of topiramate. Thiazide diuretics may increase the serum concentration of topiramate. Monitor for increased topiramate concentrations/adverse effects (e.g., hypokalemia) with initiation/dose increase of a thiazide diuretic. Closely monitor serum potassium concentrations with concomitant therapy. Topiramate dose reductions may be necessary. [drugbank_resource:DB00273_DB00880]" assertion.
- drugbank_resource:DB00273_DB00880 identifier "drugbank_resource:DB00273_DB00880" assertion.
- drugbank_resource:DB00273_DB00880 title "DDI between Topiramate and Chlorothiazide - Thiazide diuretics such as chlorothiazide may enhance the hypokalemic effect of topiramate. Thiazide diuretics may increase the serum concentration of topiramate. Monitor for increased topiramate concentrations/adverse effects (e.g., hypokalemia) with initiation/dose increase of a thiazide diuretic. Closely monitor serum potassium concentrations with concomitant therapy. Topiramate dose reductions may be necessary." assertion.
- drugbank:DB00273 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00273_DB00880 assertion.
- drugbank:DB00880 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00273_DB00880 assertion.